Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Novel Virtual Reality Treatment for Emerging Adults With ADHD

NCT06454604 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT06454604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06454604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Novel Virtual Reality Treatment for Emerging Adults With ADHD
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 3
Overall status
Completed
Start date
September 20, 2024
Completion date
July 30, 2025
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder